October 13, 2009
Recorded August 30, 2009
Robert M Califf MD
Professor of Medicine
Donald F Fortin Professor, Cardiology
Vice Chancellor for Clinical Research
Director, Duke Translational
Medicine Institute
Duke University Medical Center
Durham, NC
To view Dr Califf's conflict of interest statement, click here
Peter Sleight MD
Emeritus Professor of Cardiovascular Medicine
University of Oxford
Emeritus Fellow Exeter College, Oxford
Honorary Consultant Physician
Oxford Radcliffe NHS Trust
Oxford, UK
Dr Sleight has no relevant financial relationships to disclose.
Recorded August 30, 2009
Professor of Medicine
Donald F Fortin Professor, Cardiology
Vice Chancellor for Clinical Research
Director, Duke Translational
Medicine Institute
Duke University Medical Center
Durham, NC
To view Dr Califf's conflict of interest statement, click here
Emeritus Professor of Cardiovascular Medicine
University of Oxford
Emeritus Fellow Exeter College, Oxford
Honorary Consultant Physician
Oxford Radcliffe NHS Trust
Oxford, UK
Dr Sleight has no relevant financial relationships to disclose.
Dr Robert Califf conducts a series of in-depth and personal interviews with his peers in the world of cardiology to find out what makes them tick, how they feel about the future, and what lessons they have learned during their exceptional careers.
In Episode Two of the series, Dr Califf talks to Dr Peter Sleight about his San Francisco days, the people he met over the course of his career who changed his life, and the journey from ISIS to Verdi.
In Episode Two of the series, Dr Califf talks to Dr Peter Sleight about his San Francisco days, the people he met over the course of his career who changed his life, and the journey from ISIS to Verdi.
Related links:
-
ACC and AHA: Leadership in today's healthcare environment
Life and times of leading cardiologists with Rob Califf. Guest: Steve Nissen
New ONTARGET analysis shows lower not necessarily better when it comes to BP
[Clinical Conditions > Hypertension; Sep 3, 2008]
Sleight Peter. Trials and tribulations: the ISIS experience. Internal Medicine Journal; volume 22,5:583-586.
Exner DV. Is it time to expand the use of cardiac resynchronization therapy to patients with mildly symptomatic heart failure? J Am Coll Cardiol 2009; doi:10.1016/j.jacc.2009.08.013.
BMJ editorial on ARBs and risk of MI stirs tempers
[Clinical Conditions Hypertension; Dec 2, 2004]
